SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
| C/O DOMAIN ASSOCIATES, LLC |
| ONE PALMER SQUARE |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
04/12/2006
|
3. Issuer Name and Ticker or Trading Symbol
Vanda Pharmaceuticals Inc.
[ VNDA ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Explanation of Responses: |
| Remarks: |
|
| No securities are beneficially owned. |
|
/s/Kathleen K. Schoemaker, Attorney-in-Fact |
04/12/2006 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Microsoft Word 10.0.6612;POWER OF ATTORNEY
THE UNDERSIGNED hereby makes, constitutes and appoints
Kathleen K. Schoemaker and Lisa A. Kraeutler (each, an "Attorney"), with full
power of substitution, each a true and lawful attorney-in-fact for the
undersigned, in the undersigned's name, place and stead and on the undersigned's
behalf, to complete, execute and file with the United States Securities and
Exchange Commission (the "Commission"), one or more initial statements of
beneficial ownership of securities, statements of changes in beneficial
ownership of securities, annual statements of beneficial ownership of securities
or information statements pursuant to Sections 16(a), 13(d) and 13(g) of the
Securities Exchange Act of 1934 and the rules and regulations thereunder, and
any other forms, certificates, documents or instruments that an Attorney deems
necessary or appropriate in order to comply with the requirements of said
Sections 16(a), 13(d) and 13(g) and said rules and regulations.
This Power of Attorney shall remain in effect for a period of
two years from the date hereof or until such earlier date as a written
revocation thereof is filed with the Commission.
Date: January 24, 2006
/s/Brian K. Halak
Brian K. Halak
